Erratum to "Pediatric post-marketing safety systems in North America: Assessment of the current status." [Pharmacoepidemiology and Drug Safety, 24, (2015), 785-792] Doi: 10.1002/pds.3813
Publication
, Journal Article
McMahon, AW; Wharton, GT; Bonnel, R; DeCelle, M; Swank, K; Testoni, D; Cope, JU; Smith, PB; Wu, E; Murphy, MD
Published in: Pharmacoepidemiology and Drug Safety
January 1, 2016
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Pharmacoepidemiology and Drug Safety
DOI
EISSN
1099-1557
ISSN
1053-8569
Publication Date
January 1, 2016
Volume
25
Issue
1
Start / End Page
110 / 111
Related Subject Headings
- Pharmacology & Pharmacy
- 4202 Epidemiology
- 3214 Pharmacology and pharmaceutical sciences
- 1117 Public Health and Health Services
- 1115 Pharmacology and Pharmaceutical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
McMahon, A. W., Wharton, G. T., Bonnel, R., DeCelle, M., Swank, K., Testoni, D., … Murphy, M. D. (2016). Erratum to "Pediatric post-marketing safety systems in North America: Assessment of the current status." [Pharmacoepidemiology and Drug Safety, 24, (2015), 785-792] Doi: 10.1002/pds.3813. Pharmacoepidemiology and Drug Safety, 25(1), 110–111. https://doi.org/10.1002/pds.3889
McMahon, A. W., G. T. Wharton, R. Bonnel, M. DeCelle, K. Swank, D. Testoni, J. U. Cope, P. B. Smith, E. Wu, and M. D. Murphy. “Erratum to "Pediatric post-marketing safety systems in North America: Assessment of the current status." [Pharmacoepidemiology and Drug Safety, 24, (2015), 785-792] Doi: 10.1002/pds.3813.” Pharmacoepidemiology and Drug Safety 25, no. 1 (January 1, 2016): 110–11. https://doi.org/10.1002/pds.3889.
McMahon AW, Wharton GT, Bonnel R, DeCelle M, Swank K, Testoni D, et al. Erratum to "Pediatric post-marketing safety systems in North America: Assessment of the current status." [Pharmacoepidemiology and Drug Safety, 24, (2015), 785-792] Doi: 10.1002/pds.3813. Pharmacoepidemiology and Drug Safety. 2016 Jan 1;25(1):110–1.
McMahon, A. W., et al. “Erratum to "Pediatric post-marketing safety systems in North America: Assessment of the current status." [Pharmacoepidemiology and Drug Safety, 24, (2015), 785-792] Doi: 10.1002/pds.3813.” Pharmacoepidemiology and Drug Safety, vol. 25, no. 1, Jan. 2016, pp. 110–11. Scopus, doi:10.1002/pds.3889.
McMahon AW, Wharton GT, Bonnel R, DeCelle M, Swank K, Testoni D, Cope JU, Smith PB, Wu E, Murphy MD. Erratum to "Pediatric post-marketing safety systems in North America: Assessment of the current status." [Pharmacoepidemiology and Drug Safety, 24, (2015), 785-792] Doi: 10.1002/pds.3813. Pharmacoepidemiology and Drug Safety. 2016 Jan 1;25(1):110–111.
Published In
Pharmacoepidemiology and Drug Safety
DOI
EISSN
1099-1557
ISSN
1053-8569
Publication Date
January 1, 2016
Volume
25
Issue
1
Start / End Page
110 / 111
Related Subject Headings
- Pharmacology & Pharmacy
- 4202 Epidemiology
- 3214 Pharmacology and pharmaceutical sciences
- 1117 Public Health and Health Services
- 1115 Pharmacology and Pharmaceutical Sciences